Joseph Reilly

Chief Operating Officer at MINERVA NEUROSCIENCES, INC.

Net worth: 69 921 $ as of 29/09/2026

51 year

Health Technology

Consumer Services

Profile

Joseph Reilly is Chief Operating Officer & Senior Vice President at Minerva Neurosciences, Inc. since 2015.
Mr. Reilly was VP, Head-Commercial Strategy & Operations at Genzyme Corp.
from 2007 to 2013.
Mr. Reilly completed undergraduate studies at Boston College and graduate studies at Wallace E Carroll School of Management.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
MINERVA NEUROSCIENCES INC 0.04%	09/08/2026	20,872 ( 0.04% )	69 921 $	29/09/2026

Joseph Reilly active positions

Companies	Position	Start
MINERVA NEUROSCIENCES, INC.	Chief Operating Officer	31/12/2013

All active positions of Joseph Reilly

Former positions of Joseph Reilly

Companies	Position	End
Genzyme Corp. Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology	Corporate Officer/Principal	30/11/2013

See the detail of Joseph Reilly's experience

Education of Joseph Reilly

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Joseph Reilly's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Genzyme Corp. Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology	Health Technology
Boston College Boston College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Wallace E Carroll School of Management Wallace E Carroll School of Management Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Minerva Neurosciences, Inc. Minerva Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes drugs to treat patients suffering from central nervous system diseases	Health Technology